albendazole has been researched along with Atherosclerotic Parkinsonism in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rotenone (1." | 1.51 | Hypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease. ( Abd El Fattah, MA; Ahmed, LA; El-Sayeh, BM; Kandil, EA; Sayed, RH, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kandil, EA | 1 |
| Sayed, RH | 1 |
| Ahmed, LA | 1 |
| Abd El Fattah, MA | 1 |
| El-Sayeh, BM | 1 |
1 other study available for albendazole and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Hypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease.
Topics: Albendazole; Animals; Behavior, Animal; Cell Death; Cell Survival; Disease Models, Animal; Dopaminer | 2019 |